Jean-Sébastien Hoffmann

20PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsAstroparticle physics and particle cosmologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 31, 2024
Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.

Audrey Lumeau, Nicolas Bery, Audrey Francès

|Oct 27, 2023
Exploring the basis of heterogeneity of cancer aggressiveness among the mutated POLE variants.

Janick Selves, Helena de Castro E Gloria, Anne-Cécile Brunac

|Jun 28, 2023
High Expression of MRE11A Is Associated with Shorter Survival and a Higher Risk of Death in CRC Patients.

Daniel de Barcellos Azambuja, Helena de Castro E Gloria, Gabriel E Silva Montenegro

|Mar 14, 2023
The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity.

Guillaume Labrousse, Pierre Vande Perre, Genis Parra

|Sep 10, 2021
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors.

Pascale Palassin, Marion Lapierre, Samuel Pyrdziak

|Aug 27, 2021
Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer.

Camille Franchet, Jean-Sébastien Hoffmann, Florence Dalenc

Pageof 4

Frequent Collaborators

4 joint publications

Valérie Bergoglio

3 joint publications

Jenifer Saffi

2 joint publications

Marie-Jeanne Pillaire

2 joint publications

Malik Lutzmann